VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

Stock Comparison

Becton, Dickinson and Company vs Stevanato Group S.p.A.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Becton, Dickinson and Company

BDX · New York Stock Exchange

Market cap (USD)$53.1B
Gross margin (TTM)46.5%
Operating margin (TTM)10.6%
Net margin (TTM)5.3%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
Data as of2025-12-31
Moat score
66/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.

View BDX analysis

Stevanato Group S.p.A.

STVN · New York Stock Exchange

Market cap (USD)$4.9B
Gross margin (TTM)29%
Operating margin (TTM)16.6%
Net margin (TTM)11.8%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryIT
Data as of2026-05-27
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Stevanato Group S.p.A.'s moat claims, evidence, and risks.

View STVN analysis

Comparison highlights

  • Moat score gap: Becton, Dickinson and Company leads (66 / 100 vs 61 / 100 for Stevanato Group S.p.A.).
  • Segment focus: Becton, Dickinson and Company has 5 segments (29.5% in Medical Essentials); Stevanato Group S.p.A. has 3 segments (47% in High-Value Solutions).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Strong.
  • Moat breadth: Becton, Dickinson and Company has 7 moat types across 3 domains; Stevanato Group S.p.A. has 8 across 3.

Primary market context

Becton, Dickinson and Company

Medical Essentials

Market

Single-use medical consumables and specimen collection systems

Geography

Global

Customer

Healthcare providers and clinical labs

Role

Manufacturer

Revenue share

29.5%

Stevanato Group S.p.A.

High-Value Solutions

Market

High-value primary packaging and integrated solutions for injectable drugs

Geography

Global

Customer

Pharmaceutical, biotechnology, and life sciences companies; fill-finish CMOs

Role

Primary packaging/component manufacturer (ready-to-use), plus supporting services

Revenue share

47%

Side-by-side metrics

Becton, Dickinson and Company
Stevanato Group S.p.A.
Ticker / Exchange
BDX - New York Stock Exchange
STVN - New York Stock Exchange
Market cap (USD)
$53.1B
$4.9B
Gross margin (TTM)
46.5%
29%
Operating margin (TTM)
10.6%
16.6%
Net margin (TTM)
5.3%
11.8%
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
HQ country
US
IT
Primary segment
Medical Essentials
High-Value Solutions
Market structure
Competitive
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Weak
Strong
Moat score
66 / 100
61 / 100
Moat domains
Demand, Supply, Legal
Demand, Supply, Network
Last update
2025-12-31
2026-05-27

Moat coverage

Shared moat types

Operational ExcellenceLong Term ContractsDesign In Qualification

Becton, Dickinson and Company strengths

Installed Base ConsumablesCompliance AdvantageData Workflow LockinSwitching Costs General

Stevanato Group S.p.A. strengths

Capex Knowhow ScaleDe Facto StandardBrand TrustService Field NetworkScope Economies

Segment mix

Becton, Dickinson and Company segments

Full profile >

Medical Essentials

Competitive

29.5%

Connected Care

Oligopoly

20.9%

BioPharma Systems

Oligopoly

10.6%

Interventional

Competitive

23.9%

Life Sciences

Oligopoly

15.1%

Stevanato Group S.p.A. segments

Full profile >

High-Value Solutions

Oligopoly

47%

Other Containment and Delivery Solutions

Competitive

44%

Engineering

Competitive

9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.